MedTrace Logo

A Study of a Probiotic in Atopic Dermatitis

NCT00893230 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2009-05-05

No results posted yet for this study

Summary

The aim of this study was to assess the clinical effect of Lactobacillus sakei supplementation in children with atopic dermatitis.

Conditions

Interventions

DIETARY_SUPPLEMENT

probiotic L sakei KCTC 10755BP

freeze-dried, 50,0000,0000 colony-forming units, twice daily, for 12 weeks

DIETARY_SUPPLEMENT

microcrystalline cellulose (placebo)

freeze-dried, 50,0000,0000 colony-forming units, twice daily, for 12 weeks

Sponsors & Collaborators

  • Yeungnam University Hospital

    collaborator OTHER

  • Korea Research Institute of Bioscience & Biotechnology

    collaborator OTHER_GOV

  • Gachon University Gil Medical Center

    collaborator OTHER

  • Chungbuk National University

    lead OTHER

Principal Investigators

  • Youn-Soo Hahn, MD, PhD · Department of Pediatrics, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Korea,

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00893230 on ClinicalTrials.gov